Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 80.83

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (277)	2/12/2003 9:45:04 PM
From: Jibacoa	of 3722

AVN Was down 17.79% today on volume of 2.48M (about 12x its daily average) after it reported financial results for the 1stQ and the fiscal year ended December 31. biz.yahoo.com The revenues suffered when compared to the 1st Q the previous year, since it didn't have the $5M payment it received from GSK and earning suffered due to increased R&D expenses related to having several products in clinical trials.<g> The stock didn't completely retrace yesterday's gain and although it tested its October 28 H of 1.29 it was able to close above it. The net loss per share for the 1stQ was $0.07 compared with an income of $0.04 the previous year. And AVN reportedly had $27M in cash on Dec.31 and a working capital of $20M on December 31, compared to $13.2M in cash and a working capital of $5.9M on Sep.30 siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next